In it, peripheral blood mononuclear cell (PBMC)-derived T cells exposed to tumor cells were injected intralesionally, and into metastatic lymph nodes, pleural and peritoneal spaces along with IL-2, yielding complete or partial responses in 36.4% (4/11). Here, IL2 is linked to neoplasm.